An RN has just completed venipuncture for blood specimens on four assigned patients during morning rounds and brings the unlabeled tubes to the nursing station to label them all together. Which is the safest action?

The Joint Commission National Patient Safety Goal NPSG.01.01.01 (improve the accuracy of patient identification) and CLSI GP33 require that specimen tubes be labeled at the bedside, immediately after collection, after verifying two unique patient identifiers (such as full name and date of birth) against the patient's wristband and the patient's self-stated identifiers when possible. Carrying unlabeled specimens to a central area is a leading cause of mislabeling sentinel events that result in transfusion of incompatible blood, missed diagnoses, and treatment of the wrong patient. Choices 1 and 2 still violate point-of-care labeling. Choice 4 inappropriately subjects four patients to repeat venipuncture instead of correcting the workflow.

In-depth explanation

Specimen mislabeling is one of the most preventable causes of harm in hospitals. The principle is "label the tube in the presence of the patient, immediately after collection, before leaving the room." Two-identifier verification must occur at the point of labeling, not at the nursing station — otherwise the chain of identification is broken. Bringing unlabeled tubes to a central area, even with a witness, is the precise scenario described in multiple Joint Commission sentinel event alerts on wrong-blood-in-tube events. The right corrective action is to take the tubes back to each bedside, re-verify identity, and label there.

Clinical scenario

<p>An RN has just completed <strong>venipuncture for blood specimens</strong> on <strong>four assigned patients</strong> during morning rounds. The unlabeled tubes are in a tray at the nursing station, and the printed laboratory orders are laid out next to them.</p>

Key concepts

• Two-Identifier Verification — Joint Commission NPSG.01.01.01 standard requiring two unique patient identifiers (commonly full name and date of birth, or medical record number) to be confirmed before any specimen, medication, treatment, or transfusion. Identifiers must be verified at the point of care, not at a central station.
• Point-of-Care Labeling — Practice of labeling specimens at the bedside, in the presence of the patient, immediately after collection. Required by CLSI GP33 and Joint Commission to prevent specimen mix-ups, particularly for blood bank samples where mislabeling can cause fatal hemolytic transfusion reactions.
• Wrong-Blood-in-Tube (WBIT) Error — A specimen labeled with the identity of a different patient than the source of the blood. A leading cause of fatal ABO-incompatible transfusion. Almost always preventable by strict point-of-care labeling and two-identifier verification.